CVX vs. JNJ: Chevron vs. Johnson & Johnson Stock Comparison
How do Chevron (CVX) and Johnson & Johnson (JNJ) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Chevron (CVX) is classified in the Energy sector (Energy), whereas Johnson & Johnson (JNJ) belongs to Health Care (Pharmaceuticals, Biotechnology & Life Sciences) — their GICS classifications point to very different parts of the market.
| Profile Item | CVX | JNJ |
|---|---|---|
| Name | Chevron Corporation | Johnson & Johnson |
| Country/Region | United States | United States |
| GICS Sector | Energy | Health Care |
| GICS Industry Group | Energy | Pharmaceuticals, Biotechnology & Life Sciences |
| GICS Industry | Oil, Gas & Consumable Fuels | Pharmaceuticals |
| GICS Sub-Industry | Integrated Oil & Gas | Pharmaceuticals |
| Market Capitalization | 414.86 billion USD | 664.95 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | January 2, 1962 | January 2, 1962 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | CVX | JNJ |
|---|---|---|
| Total Return (1Y) | 42.24% | 53.82% |
| Total Return (3Y, Annualized) | 19.22% | 27.51% |
| Total Return (5Y, Annualized) | 17.45% | 14.71% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | CVX | JNJ |
|---|---|---|
| Volatility (1Y, Annualized) | 24.66% | 21.23% |
| Beta (5Y) | 0.50 | 0.21 |
| Max Drawdown (5Y) | -24.95% | -18.41% |
| Avg. Volume (3M) | 8.39M | 6.93M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | CVX | JNJ |
|---|---|---|
| Sharpe Ratio (1Y) | 1.54 | 2.33 |
| Sortino Ratio (1Y) | 2.26 | 3.66 |
Profitability
ROE (TTM)
Johnson & Johnson (JNJ) at 20.02% sits in the top ROE quartile, while Chevron (CVX) at 13.85% is closer to the peer norm — stronger capital efficiency for JNJ.
CVX
Energy industry group
13.85%
- Max
- 53.85%
- Q3
- 24.79%
- CVX
- 13.85%
- Median
- 12.85%
- Q1
- 2.03%
- Min
- -29.09%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
20.02%
- Max
- 109.18%
- JNJ
- 20.02%
- Q3
- 6.23%
- Median
- -26.66%
- Q1
- -64.05%
- Min
- -167.77%
Net Margin (TTM)
Johnson & Johnson (JNJ) at 16.20% retains a top-quartile share of revenue as profit, ahead of Chevron (CVX) at 11.92%, which keeps about the industry-typical share.
CVX
Energy industry group
11.92%
- Max
- 56.92%
- Q3
- 22.92%
- CVX
- 11.92%
- Median
- 10.10%
- Q1
- 0.07%
- Min
- -27.38%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
16.20%
- Max
- 18.05%
- JNJ
- 16.20%
- Q3
- 4.78%
- Median
- 0.00%
- Q1
- -4.14%
- Min
- -17.05%
Operating Margin (TTM)
Johnson & Johnson (JNJ) at 25.74% operates in the top operating margin quartile, ahead of Chevron (CVX) at 17.89%, which runs around its industry’s norm.
CVX
Energy industry group
17.89%
- Max
- 71.31%
- Q3
- 33.75%
- Median
- 18.73%
- CVX
- 17.89%
- Q1
- 6.94%
- Min
- -24.52%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
25.74%
- Max
- 83.12%
- JNJ
- 25.74%
- Q3
- 14.77%
- Median
- 0.00%
- Q1
- -78.82%
- Min
- -207.40%
Profitability Metrics
| Metric | CVX | JNJ |
|---|---|---|
| ROE (TTM) | 13.85% | 20.02% |
| ROA (TTM) | 6.47% | 8.46% |
| Net Margin (TTM) | 11.92% | 16.20% |
| Operating Margin (TTM) | 17.89% | 25.74% |
| Gross Margin (TTM) | 44.39% | 67.78% |
Growth
Revenue Growth
Both Chevron (CVX) at -4.64% and Johnson & Johnson (JNJ) at 6.05% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Johnson & Johnson (JNJ) at 90.50% sits in the top EPS growth quartile, while Chevron (CVX) at -31.79% is closer to the peer norm — faster per-share earnings growth for JNJ.
Growth Metrics
| Metric | CVX | JNJ |
|---|---|---|
| Revenue Growth (YoY) | -4.64% | 6.05% |
| Revenue Growth (3Y CAGR) | -7.85% | 5.60% |
| EPS Growth (YoY) | -31.79% | 90.50% |
| EPS Growth (3Y CAGR) | -28.69% | 17.90% |
Financial Strength
Current Ratio (MRQ)
Chevron (CVX) at 1.34 keeps current ratio within its industry’s typical mid-range, while Johnson & Johnson (JNJ) at 1.02 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for JNJ.
CVX
Energy industry group
1.34
- Max
- 3.64
- Q3
- 2.21
- Median
- 1.41
- CVX
- 1.34
- Q1
- 0.88
- Min
- 0.24
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.02
- Max
- 25.13
- Q3
- 12.13
- Median
- 5.52
- Q1
- 2.47
- JNJ
- 1.02
- Min
- 0.10
Debt / Equity (MRQ)
Chevron (CVX) at 0.17 keeps leverage in the lower industry quartile, while Johnson & Johnson (JNJ) at 0.55 runs a more typical debt-to-equity mix.
CVX
Energy industry group
0.17
- Max
- 1.75
- Q3
- 0.93
- Median
- 0.54
- Q1
- 0.30
- CVX
- 0.17
- Min
- 0.00
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.55
- Max
- 1.42
- Q3
- 0.65
- JNJ
- 0.55
- Median
- 0.15
- Q1
- 0.02
- Min
- 0.00
Financial Strength Metrics
| Metric | CVX | JNJ |
|---|---|---|
| Current Ratio (MRQ) | 1.34 | 1.02 |
| Debt / Equity (MRQ) | 0.17 | 0.55 |
| Net Debt / EBITDA | 0.36 | 0.79 |
Dividends
Dividend Yield (TTM)
Chevron (CVX) at 3.31% pays an industry-typical yield; Johnson & Johnson (JNJ) at 1.94% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.
CVX
Energy industry group
3.31%
- Max
- 8.57%
- Q3
- 3.58%
- CVX
- 3.31%
- Median
- 1.71%
- Q1
- 0.00%
- Min
- 0.00%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.94%
- JNJ
- 1.94%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Chevron (CVX) at 51.76% keeps its payout in the industry’s typical band, while Johnson & Johnson (JNJ) at 80.12% pays out more than any of its peers — the most stretched cover in its group.
CVX
Energy industry group
51.76%
- Max
- 133.24%
- Q3
- 53.31%
- CVX
- 51.76%
- Median
- 25.24%
- Q1
- 0.00%
- Min
- 0.00%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
80.12%
- JNJ
- 80.12%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | CVX | JNJ |
|---|---|---|
| Dividend Yield (TTM) | 3.31% | 1.94% |
| Dividend Payout Ratio (TTM) | 51.76% | 80.12% |
Valuation
P/E Ratio (TTM)
Both Chevron (CVX) at 15.61 and Johnson & Johnson (JNJ) at 41.92 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
CVX
Energy industry group
15.61
- Max
- 39.54
- Q3
- 21.72
- CVX
- 15.61
- Median
- 12.19
- Q1
- 7.71
- Min
- 2.99
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
41.92
- Max
- 85.34
- Q3
- 43.46
- JNJ
- 41.92
- Median
- 26.69
- Q1
- 13.30
- Min
- 0.07
P/S Ratio (TTM)
On P/S ratio, both Chevron (CVX) at 1.83 and Johnson & Johnson (JNJ) at 6.69 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.
CVX
Energy industry group
1.83
- Max
- 5.40
- Q3
- 2.85
- CVX
- 1.83
- Median
- 1.69
- Q1
- 0.88
- Min
- 0.00
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
6.69
- Max
- 58.18
- Q3
- 25.77
- Median
- 7.30
- JNJ
- 6.69
- Q1
- 3.01
- Min
- 0.01
P/B Ratio (MRQ)
Chevron (CVX) at 2.13 is valued about in line with its industry on P/B ratio, while Johnson & Johnson (JNJ) at 8.16 carries an above-peer premium to book — JNJ is pricier on assets.
CVX
Energy industry group
2.13
- Max
- 4.21
- Q3
- 2.38
- CVX
- 2.13
- Median
- 1.51
- Q1
- 1.08
- Min
- 0.01
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
8.16
- Max
- 13.53
- JNJ
- 8.16
- Q3
- 6.54
- Median
- 3.25
- Q1
- 1.69
- Min
- -5.59
Valuation Metrics
| Metric | CVX | JNJ |
|---|---|---|
| P/E Ratio (TTM) | 15.61 | 41.92 |
| P/S Ratio (TTM) | 1.83 | 6.69 |
| P/B Ratio (MRQ) | 2.13 | 8.16 |
| Free Cash Flow Yield (TTM) | 6.28% | 2.78% |